BioSpace News Archive

Pharm Country

Women of Color in Pharma (WOCIP) Conference Agenda Showcases Innovation And Leadership

Women of Color in Pharma (WOCIP) has released the agenda for its second annual conference on Nov. 2 and 3 at The Westin in Princeton, N.J.

October 5, 2018
·
2 min read
Genetown

Goldfinch Bio to Present Data on TRPC5 Inhibitor for Proteinuric Kidney Disease and its Kidney Genome Atlas for Identification of Novel Targets

Goldfinch Bio, a biotechnology company focused on discovering and developing precision medicines for the treatment of genetically-informed kidney diseases, today announced that five abstracts were selected for presentation at the American Society of Nephrology (ASN) Kidney Week 2018 Conference being held October 23-28, 2018 in San Diego.

October 5, 2018
·
3 min read
FDA

Breckenridge Announces Final Approval of its ANDA for Roflumilast Tablets (Daliresp®)

Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for its Abbreviated New Drug Application for Roflumilast Tablets, 500mcg, generic for Daliresp® Tablets by AstraZeneca Pharmaceutical LP.

October 5, 2018
·
2 min read
Genetown

Thousands Will Stand in Solidarity Against Cancer on October 19th

On October 19, 2018, thousands of people across the country will stand in solidarity with those affected by cancer as part of National Be Bold, Be Bald! Day.

October 5, 2018
·
2 min read
Concordia International Corp. Announces Special Meeting of Shareholders To Approve Name Change

Concordia International Corp. (“Concordia” or the “Company”) (TSX: CXR), today issued a notice of meeting (the “Meeting”) of shareholders to consider and approve a name change (the “Name Change”) of the Company.

October 5, 2018
·
4 min read
Policy

FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine.

October 5, 2018
·
3 min read
FDA

FDA Approves Revcovi™, a New Enzyme Replacement Therapy Developed by Leadiant Biosciences, for the Treatment of ADA-SCID in Pediatric and Adult Patients

Leadiant Biosciences, Inc. today announced that the Food and Drug Administration (FDA) has granted approval to Revcovi™ (elapegademase-lvlr) injection in the U.S. Revcovi is a new enzyme replacement therapy (ERT) for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients.

October 5, 2018
·
9 min read
Business

Child Mind Institute Co-Founder Debra Perelman Honored For Her Leadership To Improve Treatment For Childhood Mental Health Issues

One in Five Children has a Diagnosable Mental Health Issue; Many Don’t Get Help

October 5, 2018
·
4 min read
Business

The Ryan Gordy Foundation In Partnership With Teen Cancer America Is Set To Host Its Inaugural Wellness Golf Classic

To raise awareness, educate, and inspire healthy living through wellness to lower the risk of cancer in young adults

October 5, 2018
·
2 min read
Drug Development

Cavion Announces Promising Phase 2 Data for Essential Tremor in T-CALM Proof-of-Concept Study

Totality of Data Demonstrates CX-8998 is Well Tolerated with Compelling Evidence of Efficacy Despite Missing Primary Endpoint Measured Using Central Video Rating

October 5, 2018
·
7 min read